Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin versus pioglitazone for glycemic control in type 2 diabetes
IRCT201704246712N3Phase 3Completed
- Sponsor
- Research Deputy of Tabriz University of Medical Sciences
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of sitagliptin and pioglitazone in type 2 diabetes mellitus (T2DM) (2 arms), sponsored by Research Deputy of Tabriz University of Medical Sciences. Started Sep 2016; status: completed.
02
Drugs
sitagliptinpioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on IRCT201704246712N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT201704246712N3.